News about Josep Maria Miró
Dr. Josep M. Miró receives the 2025 Josep Trueta Award from the Academy
The award, which recognizes his career in infectious diseases research, was presented on May 20 during the closing ceremony of the academic year at t1
New breakthrough in preventing infections in biomedical implants
Infections associated with medical implants are a serious health issue. A new research project financed by La Marató TV3 presents a chemical modifica1
Dr. Miró, nominated elected academic member of the Royal Academy of Medicine of Catalonia
The senior consultant in the Infectious Diseases Service was inducted with a speech about the 40 years he has been working on HIV-AIDS
Josep Maria Miró, IDIBAPS researcher, has been honoured as a Fellow of IDSA by the Infectious Diseases Society of America
Josep Maria Miró is head of the Endocarditis. Cardiovascular Infections. Experimental Model group and Senior Consultant in the Infectious Diseases Se1
Discovery of a new genetic variant associated with a slow progression of HIV infection
An international study involving IrsiCaixa and the Hospital Clínic-IDIBAPS, published today in the journal Nature, identifies a change in the human g1
IDIBAPS opens the doors to its laboratories to show research carried out thanks to La Marató, a telethon organised by TV3 and Catalunya Ràdio
Four visits were organised this year: two devoted to a research project on mantle cell lymphoma; and two to a project aimed at preventing intravenous1
The diagnostic criteria for infective endocarditis have been updated
Researchers at the Hospital Clínic-IDIBAPS have coordinated the update of the criteria for the diagnosis of infective endocarditis, published in the1
A unique case of a functional cure of the HIV virus
This latest case of functional cure sheds new light on the mechanisms through which certain people are able to control the virus after receiving anti1
Determinants associated with a severe form of COVID-19 in people living with HIV in Catalonia identified
The results show that people with HIV with chronic comorbidities and an unsuppressed HIV viral load could be at greater risk of developing severe COV1